HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Franck Halary Selected Research
Franck Halary Research Topics
Disease
8
Infections
10/2021 - 11/2002
1
Kidney Diseases (Kidney Disease)
10/2021
1
COVID-19
02/2021
1
Viremia
02/2021
1
Neoplasms (Cancer)
01/2019
1
Merkel Cell Carcinoma
01/2019
1
Carcinoma (Carcinomatosis)
01/2016
1
Diarrhea
01/2016
1
Malaria
12/2011
1
Reactive Arthritis (Reiter Disease)
02/2002
Drug/Important Bio-Agent (IBA)
6
DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)
IBA
10/2021 - 11/2002
3
Glycoproteins (Glycoprotein)
IBA
10/2021 - 01/2019
3
DNA (Deoxyribonucleic Acid)
IBA
02/2021 - 01/2016
3
C-Type Lectins (C-Type Lectin)
IBA
06/2019 - 01/2018
2
Ligands
IBA
01/2019 - 01/2018
2
Proteins (Proteins, Gene)
FDA Link
01/2019 - 01/2019
1
Calixarenes (Calixarene)
IBA
10/2021
1
Glycoconjugates
IBA
10/2021
1
Hydroxamic Acids (Hydroxamic Acid)
IBA
10/2021
1
Acids
IBA
10/2021
1
calix(4)arene
IBA
10/2021
1
Calcineurin Inhibitors
IBA
02/2021
1
Mycophenolic Acid (Cellcept)
FDA Link
Generic
02/2021
1
chenodeoxycholate sulfate conjugate (CDCS)
IBA
01/2021
1
Biological Products
IBA
01/2019
1
Polysaccharides (Glycans)
IBA
01/2019
1
Antigens
IBA
01/2019
1
Viral Structural Proteins (VP(1))
IBA
01/2019
1
Nonsense Codon (Nonsense Mutation)
IBA
01/2019
1
Antiparasitic Agents (Antiparasitics)
IBA
12/2011
1
Antibodies
IBA
11/2002
1
Interleukin-10 (Interleukin 10)
IBA
02/2002
1
HLA-B*27:05 antigen
IBA
02/2002
Therapy/Procedure
1
Complementary Therapies (Alternative Medicine)
10/2021